GLP-1 medications mostly reduce fat mass, but clinical body-composition substudies show some lean mass loss is real. The practical answer is not panic, it is protein, resistance training, slower loss when appropriate, and tracking strength, not just scale weight.
One targets GLP-1 receptors. The other targets GLP-1 and GIP. Clinical trials show tirzepatide edges out semaglutide on weight loss — but the full picture is more nuanced.
Hormonal shifts after 40 make weight loss harder. GLP-1 medications can help — but the research on women specifically tells a different story than the headlines.
Most people notice appetite changes within 1-2 weeks, but meaningful weight loss takes 8-12 weeks. Here's the realistic week-by-week timeline from clinical trials.
GLP-1s work without strict dieting — but the research shows that adding protein and resistance training dramatically improves results and prevents muscle loss.
There are dozens of online weight loss programs. Most aren't worth your money. We reviewed the ones that are — ranked by pricing, medications, and the support you actually get.
Same active ingredient, 80% cheaper. So what's the catch? An honest look at the differences between FDA-approved Ozempic and compounded semaglutide — and how to decide.
Brand Zepbound costs $1,069/month. Compounded tirzepatide starts around $249/month. But is it legit? Here's what real users report and what to look for.
Without insurance, brand-name GLP-1s cost $12,000–$16,000 per year. Here are real, legal ways to get the same medications for $149–$349/month — no insurance needed.
Compounded GLP-1s cost a fraction of brand-name Wegovy or Zepbound. But are they the same drug? An honest breakdown of 503A vs 503B pharmacies, what's identical, what's different, and how to decide.
Wegovy costs $1,350/month. Zepbound costs $1,069/month. Here's how to pay 50–80% less — through insurance navigation, manufacturer savings programs, compounding pharmacies, and telehealth platforms starting at $149/mo.
Starting Ozempic, Wegovy, or Mounjaro and wondering about drinking? Research shows GLP-1s significantly reduce alcohol cravings — but also change your tolerance in ways that matter practically.
Most people regain two-thirds of their lost weight within a year of stopping GLP-1 medications. Here's what the clinical trials show, why it happens biologically, and practical strategies to minimize regain.
Up to 70% of GLP-1 patients experience side effects — but most are manageable and temporary. This evidence-based guide covers what to expect at each phase of treatment and practical strategies for every common side effect.
New research from the Technical University of Munich and Harvard Medical School reveals that semaglutide and tirzepatide don't just promote weight loss — they appear to fundamentally reshape the body's metabolic and inflammatory pathways in ways researchers didn't fully anticipate.
New research from the University of Eastern Finland has found that semaglutide (Ozempic/Wegovy) is associated with significantly reduced rates of depression, anxiety, and substance use disorders — adding to a growing body of evidence that GLP-1 drugs do far more than cause weight loss.
The Trump administration announced deals with Eli Lilly and Novo Nordisk to significantly reduce the cost of weight loss medications through TrumpRx. Here's what we know and what it means for people taking semaglutide or tirzepatide.